Close Menu

Dennis Shin

Apr 10, 2018

Precision oncology company Syapse has hired Dennis Shin as chief commercial officer. Shin, who has extensive experience with health system partnerships with and physician-focused IT systems, joins Syapse after 22 years at the Advisory Board Co., where he most recently was senior vice president of national and strategic accounts.

More Like This

Apr 23, 2019

Bahija Jallal

Guardant Health has appointed Bahija Jallal to its Board of Directors, effective April 17. Jallal has served as the CEO of Immunocore Limited, a T cell receptor biotechnology company, since January 2019. Prior to that she served as executive vice president of AstraZeneca PLC and was president of MedImmune, a subsidiary of AstraZeneca after holding various other research and development positions at the company.

Jallal is a member of the of the Board of Trustees of Johns Hopkins University and of UMB Health Sciences Research Park Corporation, and served as past president of the Association for Women in Science.

Apr 23, 2019

Joseph Frendo

Caris Life Sciences announced Joseph Frendo has joined the company as chief operations officer. He was senior vice president of PBM Operations at CVS health. Prior to that, he held various management positions at Medco Health Solutions. In his role at Caris, Frendo will direct technical and clinical staff operations and guide strategies to advance quality and optimize efficiences across the firm, Caris said. 

 

Apr 23, 2019

Melody Harris

SomaLogic has appointed Melody Harris as the firm's president. Harris joined the firm as its chief legal officer in 2018 from Qualcomm Life. Harris previously served as general counsel at HealthyCircles before it was acquired by Qualcomm. Prior to HealthyCircles, Harris held a variety of executive leadership roles at a consulting firm in the broadcasting space. 

Apr 22, 2019

Richard Wenstrup

Epic Sciences has appointed Richard Wenstrup as its chief medical officer. Wenstrup has served in several clinical leadership roles managing life science companies in the past 25 years. Before Epic, he previously served as CMO for Oxford Immunotec, where he oversaw research and development, product development, regulatory, medical, and clinical affairs. From 2006 to 2017, Wenstrup served as CMO at Myriad Genetics. Prior to Myriad, Wenstrup was a pediatrics professor in human genetics at Cincinnati Children's Hospital Medical Center and professor of biomedical engineering at the University of Cincinnati. 

Apr 18, 2019

Ori Karev

Ori Karev has joined Precipio as chief strategy officer. Karev was formerly CEO of UnitedHealthcare Global, the international division of United Healthcare. He also previously worked for Ernst & Young. An attorney by training, Karev has more than 30 years of experience in the healthcare, insurance, and mobility industries, Precipio said.

Apr 17, 2019

Carsten Ullrich

Centogene has appointed Carsten Ullrich its director of artificial intelligence. He will direct the firm's use of AI to enhance diagnostic effectiveness and quality, and to discover new insights, accelerate biomarker development, and drive solutions for drug firms. Ullrich was most recently associate head of a research lab and senior researcher at the German Research Center for Artifidal Intelligence. 

Apr 16, 2019

Marijn Dekkers

Marijn Dekkers has been named chairman of the board of synthetic biology firm Ginkgo Bioworks. He also will serve as a strategic advisor of the Boston-based company. Dekkers most recently served as CEO of Bayer AG, and prior to that was CEO of Thermo Fisher Scientific. He also currently serves as chairman of Unilever and is founder and chairman of Novalis LifeSciences, a boutique investment and advisory firm.

Apr 15, 2019

James Corbett

PerkinElmer said recently that Executive Vice President and President of Discovery & Analytical Solution James Corbett is leaving the company on April 30. His departure follows a "conversation" between PerkinElmer and Corbett, the company said in a document filed with the US Securities and Exchange Commission. 

Apr 05, 2019

Andrew Brooks

Circuit Clinical, an integrated research organization that facilitates clinical trials and biospecimen collection, has added Andrew Brooks to its board of directors. Brooks is currently chief operating officer of RUCDR Infinite Biologics (RUCDR) at Rutgers University, the world's largest academic biorepository managing biological resources for clients such as the National Institutes of Health, as well as leading academic researchers and major pharmaceutical and biotechnology companies. He is a professor of genetics at Rutgers University and a member of the Human Genetics Institute of New Jersey.

Apr 05, 2019

Joseph Driscoll

Akoya Biosciences, which markets tools for high-parameter tissue analysis and biomarker discovery, has appointed Joseph Driscoll as CFO. Driscoll most recently served as CFO at Quanterix. He has also served as CFO at several other public and private companies, including Verscend, PC Connection, Summer Infant, ACT Electronics, and Safety 1[st].

Apr 03, 2019

Ilan Daskal

Bio-Rad Laboratories has appointed Ilan Daskal as executive vice president and CFO. Daskal previously served as CFO of Lumileds, a lighting manufacturer formed in 1999 as a joint venture between Philips Lighting and Agilent Technologies. He will replace Christine Tsingos, who is retiring.

Apr 03, 2019

James Marsden

LexaGene has appointed James Marsden to its scientific advisory board. Marsden previously served as the executive director of food safety at Chipotle from 2016 to 2019. According to LexaGene, Marsden has also worked for several food companies and techology providers. Prior to Chipotle, he acted as VP for scientific affairs and President at the American Meat Institute. In addition, Marsden also held the role of a professor at Kansas State University. 

Apr 02, 2019

Aaron Tachibana

Personalis has appointed Aaron Tachibana as CFO. Tachibana previously served as CFO of Lumentum Holdings. Prior to joining Lumentum, Tachibana was VP of finance at JDS Uniphase. He holds a BS in business administration and finance from San Jose State University. 

Apr 02, 2019

Flemming Ornskov

Flemming Ornskov was appointed to Centogene's supervisory board and elected its non-executive chairman, effective April 1. He most recently was CEO of Shire. Prior to that, he held senior positions at several pharmaceutical firms, such as Bayer, Novartis, and Merck & Co. As a non-executive chairman, Ornskov will oversee Centogene's strategy development, US expansion, and strategic M&A. 

Apr 01, 2019

Marc Williams, Karen Gripp, Dietrich Matern, Michael Murray, Cynthia Powell, Heidi Rehm

Marc Williams has been announced as president-elect of the American College of Medical Genetics and Genomics. He is the director of the Geisinger Genomic Medicine Institute. Prior to joining Geisinger in 2012, he was the director of Intermountain Healthcare's Clinical Genetics Institute. Williams is a board-certified pediatrician and holds an MD as well as an undergraduate degree in chemistry from the University of Wisconsin-Madison.

Williams and five others have also been elected to the ACMG's board of directors for a six-year term that starts this month. The other new directors are Karen Gripp, chief of the Division of Medical Genetics at the Nemours/Alfred I. duPont Hospital for Children and medical director of its molecular diagnostics laboratory; Dietrich Matern, chair of the Division of Laboratory Genetics and Genomics in the Department of Laboratory Medicine and Pathology at the Mayo Clinic; Michael Murray, director of clinical operations in the Center for Genomic Health at Yale University School of Medicine; Cynthia Powell, director of the medical residency program and medical director of the UNC Hospitals Cytogenetics Laboratory; and Heidi Rehm, chief genomics officer at Massachusetts General Hospital and medical director of the Broad Institute's clinical laboratory.

Australia will not be regulating gene editing of plants, animals, and human cell lines as long as no new genetic material is incorporated, reports Nature News.

The Washington Post reports that the US Department of Agriculture told its researchers to label peer-reviewed articles as "preliminary" work.

Researchers have sequenced the genomes of both the coast redwood and the giant sequoia, according to the San Francisco Chronicle.

In PNAS this week: study of epigenetic patterns in mammalian eggs, clonal expansion patterns in CD8+ T cells, and more.